Evidence map›Paper›PMID 38831393›Full record

ArticleBMC medical research methodology2024

Comparison of two propensity score-based methods for balancing covariates: the overlap weighting and fine stratification methods in real-world claims data.

Wen Wan, Manoradhan Murugesan, Robert S Nocon, Joshua Bolton, R Tamara Konetzka, Marshall H Chin, Elbert S Huang

Abstract readComparative Study
In one paragraph

Article in BMC medical research methodology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wen WanSection of General Internal Medicine, Department of Medicine, The University of Chicago, 5841 S. Maryland Ave, Chicago, MC, IL, 2007, 60637, USA. wwan1@medicine.bsd.uchicago.edu.
Manoradhan MurugesanDepartment of Public Health Sciences, Department of Medicine, The University of Chicago, Chicago, IL, USA.
Robert S NoconHealth Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, USA.
Joshua BoltonDepartment of Information Systems, University of Maryland, Baltimore, MD, USA.
R Tamara KonetzkaDepartment of Public Health Sciences, Department of Medicine, The University of Chicago, Chicago, IL, USA.
Marshall H ChinSection of General Internal Medicine, Department of Medicine, The University of Chicago, 5841 S. Maryland Ave, Chicago, MC, IL, 2007, 60637, USA.
Elbert S HuangSection of General Internal Medicine, Department of Medicine, The University of Chicago, 5841 S. Maryland Ave, Chicago, MC, IL, 2007, 60637, USA.

Funding

Pilot Program CoreP30ES027792 · NIEHS · UNIVERSITY OF CHICAGO · PI Gokhan M. Mutlu, Gail S Prins · 2017 to 2026
$13.6M
Research Design, Data, and Analytics CoreP30DK092949 · NIDDK · UNIVERSITY OF CHICAGO · PI Ronald T. Ackermann, MARSHALL H CHIN · 2011 to 2026
$10.0M
Chicago Center for Diabetes Translation Research NIDDK P30 DK092949HRSA HHS HHSH250201300025INIDDK NIH HHS P30 DK092949NIEHS NIH HHS P30 ES027792
6 · The paper itself

Abstract

backgroundTwo propensity score (PS) based balancing covariate methods, the overlap weighting method (OW) and the fine stratification method (FS), produce superb covariate balance. OW has been compared with various weighting methods while FS has been compared with the traditional stratification method and various matching methods. However, no study has yet compared OW and FS. In addition, OW has not yet been evaluated in large claims data with low prevalence exposure and with low frequency outcomes, a context in which optimal use of balancing methods is critical. In the study, we aimed to compare OW and FS using real-world data and simulations with low prevalence exposure and with low frequency outcomes.

methodsWe used the Texas State Medicaid claims data on adult beneficiaries with diabetes in 2012 as an empirical example (N = 42,628). Based on its real-world research question, we estimated an average treatment effect of health center vs. non-health center attendance in the total population. We also performed simulations to evaluate their relative performance. To preserve associations between covariates, we used the plasmode approach to simulate outcomes and/or exposures with N = 4,000. We simulated both homogeneous and heterogeneous treatment effects with various outcome risks (1-30% or observed: 27.75%) and/or exposure prevalence (2.5-30% or observed:10.55%). We used a weighted generalized linear model to estimate the exposure effect and the cluster-robust standard error (SE) method to estimate its SE.

resultsIn the empirical example, we found that OW had smaller standardized mean differences in all covariates (range: OW: 0.0-0.02 vs. FS: 0.22-3.26) and Mahalanobis balance distance (MB) (< 0.001 vs. > 0.049) than FS. In simulations, OW also achieved smaller MB (homogeneity: <0.04 vs. > 0.04; heterogeneity: 0.0-0.11 vs. 0.07-0.29), relative bias (homogeneity: 4.04-56.20 vs. 20-61.63; heterogeneity: 7.85-57.6 vs. 15.0-60.4), square root of mean squared error (homogeneity: 0.332-1.308 vs. 0.385-1.365; heterogeneity: 0.263-0.526 vs 0.313-0.620), and coverage probability (homogeneity: 0.0-80.4% vs. 0.0-69.8%; heterogeneity: 0.0-97.6% vs. 0.0-92.8%), than FS, in most cases.

conclusionsThese findings suggest that OW can yield nearly perfect covariate balance and therefore enhance the accuracy of average treatment effect estimation in the total population.

Indexed as

Propensity ScoreAdultComputer SimulationDiabetes MellitusFemaleHumansInsurance Claim ReviewMaleMedicaidMiddle AgedTexasUnited StatesAverage treatment effect (ATE)Covariate balanceFine stratification method (FS)Overlap weighting method (OW)Plasmode simulation methodPropensity score (PS)

Identifiers

PMID38831393
PMCPMC11145799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.